{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:31:18Z","timestamp":1793741478820,"version":"4.6.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2021-125118OB-I00"],"award-info":[{"award-number":["PID2021-125118OB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2020-113938RB-I00"],"award-info":[{"award-number":["PID2020-113938RB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-106404RB-I00"],"award-info":[{"award-number":["PID2019-106404RB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-106579RB-I00"],"award-info":[{"award-number":["PID2019-106579RB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2022-142617NB-I00"],"award-info":[{"award-number":["PID2022-142617NB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2021-SGR-00230"],"award-info":[{"award-number":["2021-SGR-00230"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023561","name":"Ministerio de Universidades","doi-asserted-by":"publisher","award":["FPU16\/02593"],"award-info":[{"award-number":["FPU16\/02593"]}],"id":[{"id":"10.13039\/501100023561","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023561","name":"Ministerio de Universidades","doi-asserted-by":"publisher","award":["FPU15\/01833"],"award-info":[{"award-number":["FPU15\/01833"]}],"id":[{"id":"10.13039\/501100023561","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cereblon\/CRBN is a substrate-recognition component of the Cullin4A-DDB1-Roc1 E3 ubiquitin ligase complex. Destabilizing mutations in the human\n                    <jats:italic>CRBN<\/jats:italic>\n                    gene cause a form of autosomal recessive non-syndromic intellectual disability (ARNSID) that is modelled by knocking-out the mouse\n                    <jats:italic>Crbn<\/jats:italic>\n                    gene. A reduction in excitatory neurotransmission has been proposed as an underlying mechanism of the disease. However, the precise factors eliciting this impairment remain mostly unknown. Here we report that CRBN molecules selectively located on glutamatergic neurons are necessary for proper memory function. Combining various in vivo approaches, we show that the cannabinoid CB\n                    <jats:sub>1<\/jats:sub>\n                    receptor (CB\n                    <jats:sub>1<\/jats:sub>\n                    R), a key suppressor of synaptic transmission, is overactivated in CRBN deficiency-linked ARNSID mouse models, and that the memory deficits observed in these animals can be rescued by acute CB\n                    <jats:sub>1<\/jats:sub>\n                    R-selective pharmacological antagonism. Molecular studies demonstrated that CRBN interacts physically with CB\n                    <jats:sub>1<\/jats:sub>\n                    R and impairs the CB\n                    <jats:sub>1<\/jats:sub>\n                    R-G\n                    <jats:sub>i\/o<\/jats:sub>\n                    -cAMP-PKA pathway in a ubiquitin ligase-independent manner. Taken together, these findings unveil that CB\n                    <jats:sub>1<\/jats:sub>\n                    R overactivation is a driving mechanism of CRBN deficiency-linked ARNSID and anticipate that the antagonism of CB\n                    <jats:sub>1<\/jats:sub>\n                    R could constitute a new therapy for this orphan disease.\n                  <\/jats:p>","DOI":"10.1038\/s44321-024-00054-w","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T15:02:32Z","timestamp":1711033352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3446-6899","authenticated-orcid":false,"given":"Carlos","family":"Costas-Insua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Hermoso-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2491-5753","authenticated-orcid":false,"given":"Estefan\u00eda","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1078-2678","authenticated-orcid":false,"given":"Carlos","family":"Montero-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"\u00c1lvaro-Bl\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4156-166X","authenticated-orcid":false,"given":"Irene B","family":"Maroto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5175-7263","authenticated-orcid":false,"given":"Andrea","family":"S\u00e1nchez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0806-9825","authenticated-orcid":false,"given":"Rebeca","family":"Diez-Alarcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7698-3926","authenticated-orcid":false,"given":"Cristina","family":"Bl\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4992-7440","authenticated-orcid":false,"given":"Enric I","family":"Canela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1764-3825","authenticated-orcid":false,"given":"Vicent","family":"Casad\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1296-6895","authenticated-orcid":false,"given":"Leyre","family":"Urig\u00fcen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gertrudis","family":"Perea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Bellocchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2582-129X","authenticated-orcid":false,"given":"Ignacio","family":"Rodr\u00edguez-Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7475-118X","authenticated-orcid":false,"given":"Manuel","family":"Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"key":"54_CR1","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/nn1916","volume":"10","author":"N Agarwal","year":"2007","unstructured":"Agarwal N, Pacher P, Tegeder I, Amaya F, Constantin CE, Brenner GJ, Rubino T, Michalski CW, Marsicano G, Monory K et al (2007) Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat Neurosci 10:870\u2013879","journal-title":"Nat Neurosci"},{"key":"54_CR2","doi-asserted-by":"publisher","first-page":"148054","DOI":"10.1016\/j.brainres.2022.148054","volume":"1793","author":"U Akber","year":"2022","unstructured":"Akber U, Bong S, Park ZY, Park CS (2022) Effects of cereblon on stress-activated redox proteins and core behavior. Brain Res 1793:148054","journal-title":"Brain Res"},{"key":"54_CR3","doi-asserted-by":"publisher","first-page":"5138","DOI":"10.1523\/JNEUROSCI.2494-20.2021","volume":"41","author":"U Akber","year":"2021","unstructured":"Akber U, Jo H, Jeon S, Yang SJ, Bong S, Lim S, Kim YK, Park ZY, Park CS (2021) Cereblon regulates the proteotoxicity of tau by tuning the chaperone activity of DNAJA1. J Neurosci 41:5138\u20135156","journal-title":"J Neurosci"},{"key":"54_CR4","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1038\/s41589-019-0366-7","volume":"15","author":"T Asatsuma-Okumura","year":"2019","unstructured":"Asatsuma-Okumura T, Ando H, De Simone M, Yamamoto J, Sato T, Shimizu N, Asakawa K, Yamaguchi Y, Ito T, Guerrini L et al (2019a) P63 is a cereblon substrate involved in thalidomide teratogenicity. Nat Chem Biol 15:1077\u20131084","journal-title":"Nat Chem Biol"},{"key":"54_CR5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.pharmthera.2019.06.004","volume":"202","author":"T Asatsuma-Okumura","year":"2019","unstructured":"Asatsuma-Okumura T, Ito T, Handa H (2019b) Molecular mechanisms of cereblon-based drugs. Pharmacol Ther 202:132\u2013139","journal-title":"Pharmacol Ther"},{"key":"54_CR6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.bcp.2018.08.007","volume":"157","author":"E Aso","year":"2018","unstructured":"Aso E, Andr\u00e9s-Benito P, Ferrer I (2018) Genetic deletion of CB1 cannabinoid receptors exacerbates the Alzheimer-like symptoms in a transgenic animal model. Biochem Pharmacol 157:210\u2013216","journal-title":"Biochem Pharmacol"},{"key":"54_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3233\/JAD-2012-111862","volume":"30","author":"E Aso","year":"2012","unstructured":"Aso E, Palomer E, Juv\u00e9s S, Maldonado R, Muoz FJ, Ferrer I (2012) CB1 agonist ACEA protects neurons and reduces the cognitive impairment of A\u03b2PP\/PS1 mice. J Alzheimer\u2019s Dis 30:439\u2013459","journal-title":"J Alzheimer\u2019s Dis"},{"key":"54_CR8","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1523\/JNEUROSCI.0599-17.2018","volume":"38","author":"CC Bavley","year":"2018","unstructured":"Bavley CC, Rice RC, Fischer DK, Fakira AK, Byrne M, Kosovsky M, Rizzo BK, Del Prete D, Alaedini A, Mor\u00f3n JA et al (2018) Rescue of learning and memory deficits in the human nonsyndromic intellectual disability cereblon knock-out mouse model by targeting the AMP-activated protein kinase\u2013mTORC1 translational pathway. J Neurosci 38:2780\u20132795","journal-title":"J Neurosci"},{"key":"54_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nm.3127","volume":"19","author":"A Busquets-Garcia","year":"2013","unstructured":"Busquets-Garcia A, Gomis-Gonz\u00e1lez M, Guegan T, Agust\u00edn-Pav\u00f3n C, Pastor A, Mato S, P\u00e9rez-Samart\u00edn A, Matute C, De La Torre R, Dierssen M et al (2013) Targeting the endocannabinoid system in the treatment of fragile X syndrome. Nat Med 19:603\u2013607","journal-title":"Nat Med"},{"key":"54_CR10","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1523\/JNEUROSCI.2081-17.2018","volume":"38","author":"TY Choi","year":"2018","unstructured":"Choi TY, Lee SH, Kim YJ, Bae JR, Lee KM, Jo Y, Kim SJ, Lee AR, Choi S, Choi LM et al (2018) Cereblon maintains synaptic and cognitive function by regulating BK channel. J Neurosci 38:3571\u20133583","journal-title":"J Neurosci"},{"key":"54_CR11","doi-asserted-by":"publisher","first-page":"7924","DOI":"10.1523\/JNEUROSCI.0821-21.2021","volume":"41","author":"C Costas-Insua","year":"2021","unstructured":"Costas-Insua C, Moreno E, Maroto IB, Ruiz-Calvo A, Bajo-Gra\u00f1eras R, Mart\u00edn-Guti\u00e9rrez D, Diez-Alarcia R, Teresa Vilar\u00f3 M, Cort\u00e9s R, Garc\u00eda-Font N et al (2021) Identification of BiP as a CB1 receptor-interacting protein that fine-tunes cannabinoid signaling in the mouse brain. J Neurosci 41:7924\u20137941","journal-title":"J Neurosci"},{"key":"54_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/ADM.0b013e31820c23fa","volume":"5","author":"RD Crean","year":"2011","unstructured":"Crean RD, Crane NA, Mason BJ (2011) An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J Addict Med 5:1\u20138","journal-title":"J Addict Med"},{"key":"54_CR13","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1111\/add.15764","volume":"117","author":"L Dellazizzo","year":"2022","unstructured":"Dellazizzo L, Potvin S, Gigu\u00e8re S, Dumais A (2022) Evidence on the acute and residual neurocognitive effects of cannabis use in adolescents and adults: a systematic meta-review of meta-analyses. Addiction 117:1857\u20131870","journal-title":"Addiction"},{"key":"54_CR14","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1002\/ajmg.a.31487","volume":"140","author":"T Dijkhuizen","year":"2006","unstructured":"Dijkhuizen T, Van Essen T, Van Der Vlies P, Verheij JBGM, Sikkema-Raddatz B, Van Der Veen AY, Gerssen-Schoorl KBJ, Buys CHCM, Kok K (2006) FISH and array-CGH analysis of a complex chromosome 3 aberration suggests that loss of CNTN4 and CRBN contributes to mental retardation in 3pter deletions. Am J Med Genet 140:2482\u20132487","journal-title":"Am J Med Genet"},{"key":"54_CR15","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nm.4128","volume":"22","author":"R Eichner","year":"2016","unstructured":"Eichner R, Heider M, Fern\u00e1ndez-S\u00e1iz V, Van Bebber F, Garz AK, Lemeer S, Rudelius M, Targosz BS, Jacobs L, Knorn AM et al (2016) Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity. Nat Med 22:735\u2013743","journal-title":"Nat Med"},{"key":"54_CR16","doi-asserted-by":"publisher","first-page":"108680","DOI":"10.1016\/j.jneumeth.2020.108680","volume":"337","author":"PF Esteban","year":"2020","unstructured":"Esteban PF, Garcia-Ovejero D, Paniagua-Torija B, Moreno-Luna R, Arredondo LF, Zimmer A, Mart\u00edn \u00c1A, Molina-Holgado E (2020) Revisiting CB1 cannabinoid receptor detection and the exploration of its interacting partners. J Neurosci Methods 337:108680","journal-title":"J Neurosci Methods"},{"key":"54_CR17","doi-asserted-by":"publisher","first-page":"114384","DOI":"10.1016\/j.expneurol.2023.114384","volume":"364","author":"A Figueiredo","year":"2023","unstructured":"Figueiredo A, Cheer JF (2023) Endocannabinoid regulation of hippocampus-dependent memory. Exp Neurol 364:114384","journal-title":"Exp Neurol"},{"key":"54_CR18","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/j.1471-4159.2011.07391.x","volume":"118","author":"CM Filipeanu","year":"2011","unstructured":"Filipeanu CM, Guidry JJ, Leonard ST, Winsauer PJ (2011) \u03949-THC increases endogenous AHA1 expression in rat cerebellum and may modulate CB1 receptor function during chronic use. J Neurochem 118:1101\u20131112","journal-title":"J Neurochem"},{"key":"54_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nature13527","volume":"512","author":"ES Fischer","year":"2014","unstructured":"Fischer ES, B\u00f6hm K, Lydeard JR, Yang H, Stadler MB, Cavadini S, Nagel J, Serluca F, Acker V, Lingaraju GM et al (2014) Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide. Nature 512:49\u201353","journal-title":"Nature"},{"key":"54_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/genes7090056","volume":"7","author":"M Gomis-Gonz\u00e1lez","year":"2016","unstructured":"Gomis-Gonz\u00e1lez M, Matute C, Maldonado R, Mato S, Ozaita A (2016) Possible therapeutic doses of cannabinoid type 1 receptor antagonist reverses key alterations in fragile X syndrome mouse model. Genes 7:56","journal-title":"Genes"},{"key":"54_CR21","doi-asserted-by":"publisher","first-page":"7932","DOI":"10.1523\/JNEUROSCI.1402-18.2018","volume":"38","author":"AJ Gonzalez-Hernandez","year":"2018","unstructured":"Gonzalez-Hernandez AJ, Maglio LE, G\u00f3mez R (2018) Cereblon regulates BK channel expression at presynaptic and postsynaptic sites in excitatory synapses. J Neurosci 38:7932\u20137934","journal-title":"J Neurosci"},{"key":"54_CR22","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/s41591-023-02381-w","volume":"29","author":"M Haney","year":"2023","unstructured":"Haney M, Vall\u00e9e M, Fabre S, Collins Reed S, Zanese M, Campistron G, Arout CA, Foltin RW, Cooper ZD, Kearney-Ramos T et al (2023) Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials. Nat Med 29:1487\u20131499","journal-title":"Nat Med"},{"key":"54_CR23","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.molcel.2020.12.046","volume":"81","author":"M Heider","year":"2021","unstructured":"Heider M, Eichner R, Stroh J, Morath V, Kuisl A, Zecha J, Lawatscheck J, Baek K, Garz AK, Rudelius M et al (2021) The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma. Mol Cell 81:1170\u20131186.e10","journal-title":"Mol Cell"},{"key":"54_CR24","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1212\/01.WNL.0000146196.01316.A2","volume":"63","author":"JJ Higgins","year":"2004","unstructured":"Higgins JJ, Pucilowska J, Lombardi RQ, Rooney JP (2004) A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardation. Neurology 63:1927\u20131931","journal-title":"Neurology"},{"key":"54_CR25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1212\/WNL.55.3.335","volume":"55","author":"JJ Higgins","year":"2000","unstructured":"Higgins JJ, Rosen DR, Loveless JM, Clyman JC, Grau MJ (2000) A gene for nonsyndromic mental retardation maps to chromosome 3p25-pter. Neurology 55:335\u2013340","journal-title":"Neurology"},{"key":"54_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3109\/01677060903567849","volume":"24","author":"JJ Higgins","year":"2010","unstructured":"Higgins JJ, Tal AL, Sun X, Hauck SCR, Hao J, Kosofosky BE, Rajadhyaksha AM (2010) Temporal and spatial mouse brain expression of cereblon, an ionic channel regulator involved in human intelligence. J Neurogenet 24:18\u201326","journal-title":"J Neurogenet"},{"key":"54_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0026-895X(25)10219-8","volume":"29","author":"AC Howlett","year":"1986","unstructured":"Howlett AC, Qualy JM, Khachatrian LL (1986) Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol Pharmacol 29:307\u2013313","journal-title":"Mol Pharmacol"},{"key":"54_CR28","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1126\/science.1177319","volume":"327","author":"T Ito","year":"2010","unstructured":"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H (2010) Identification of a primary target of thalidomide teratogenicity. Science 327:1345\u20131350","journal-title":"Science"},{"key":"54_CR29","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1111\/j.1471-4159.2005.03344.x","volume":"94","author":"S Jo","year":"2005","unstructured":"Jo S, Lee KH, Song S, Jung YK, Park CS (2005) Identification and functional characterization of cereblon as a binding protein for large-conductance calcium-activated potassium channel in rat brain. J Neurochem 94:1212\u20131224","journal-title":"J Neurochem"},{"key":"54_CR30","doi-asserted-by":"publisher","first-page":"6005","DOI":"10.1523\/JNEUROSCI.23-14-06005.2003","volume":"23","author":"T Kleppisch","year":"2003","unstructured":"Kleppisch T, Wolfsgruber W, Feil S, Allmann R, Wotjak CT, Goebbels S, Nave KA, Hofmann F, Feil R (2003) Hippocampal cGMP-dependent protein kinase I supports an age- and protein synthesis-dependent component of long-term potentiation but is not essential for spatial reference and contextual memory. J Neurosci 23:6005\u20136012","journal-title":"J Neurosci"},{"key":"54_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ajhg.2015.11.024","volume":"98","author":"K Kochinke","year":"2016","unstructured":"Kochinke K, Zweier C, Nijhof B, Fenckova M, Cizek P, Honti F, Keerthikumar S, Oortveld MAW, Kleefstra T, Kramer JM et al (2016) Systematic phenomics analysis deconvolutes genes mutated in intellectual disability into biologically coherent modules. Am J Hum Genet 98:149\u2013164","journal-title":"Am J Hum Genet"},{"key":"54_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-4939-8994-2_10","volume":"1916","author":"AK Kraeuter","year":"2019","unstructured":"Kraeuter AK, Guest PC, Sarnyai Z (2019) The Y-Maze for assessment of spatial working and reference memory in mice. Methods Mol Biol 1916:105\u2013111","journal-title":"Methods Mol Biol"},{"key":"54_CR33","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nature14610","volume":"523","author":"J Kr\u00f6nke","year":"2015","unstructured":"Kr\u00f6nke J, Fink EC, Hollenbach PW, MacBeth KJ, Hurst SN, Udeshi ND, Chamberlain PP, Mani DR, Man HW, Gandhi AK et al (2015) Lenalidomide induces ubiquitination and degradation of CK1\u03b1 in del(5q) MDS. Nature 523:183\u2013188","journal-title":"Nature"},{"key":"54_CR34","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1126\/science.1244851","volume":"343","author":"J Kr\u00f6nke","year":"2014","unstructured":"Kr\u00f6nke J, Udeshi ND, Narla A, Grauman P, Hurst SN, McConkey M, Svinkina T, Heckl D, Comer E, Li X et al (2014) Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. Science 343:301\u2013305","journal-title":"Science"},{"key":"54_CR35","first-page":"1","volume":"5","author":"J Liu","year":"2014","unstructured":"Liu J, Ye J, Zou X, Xu Z, Feng Y, Zou X, Chen Z, Li Y, Cang Y (2014) CRL4A CRBN E3 ubiquitin ligase restricts BK channel activity and prevents epileptogenesis. Nat Commun 5:1\u20139","journal-title":"Nat Commun"},{"key":"54_CR36","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.pharep.2017.06.011","volume":"69","author":"E L\u00f3pez-Dyck","year":"2017","unstructured":"L\u00f3pez-Dyck E, Andrade-Urz\u00faa F, Elizalde A, Ferrer-Villada T, Dagnino-Acosta A, Huerta M, Osuna-Calleros Z, Rangel-Sandoval C, S\u00e1nchez-Pastor E (2017) ACPA and JWH-133 modulate the vascular tone of superior mesenteric arteries through cannabinoid receptors, BKCa channels, and nitric oxide dependent mechanisms. Pharmacol Rep 69:1131\u20131139","journal-title":"Pharmacol Rep"},{"key":"54_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38026-2","volume":"14","author":"IB Maroto","year":"2023","unstructured":"Maroto IB, Costas-Insua C, Berthoux C, Moreno E, Ruiz-Calvo A, Montero-Fern\u00e1ndez C, Mac\u00edas-Camero A, Mart\u00edn R, Garc\u00eda-Font N, S\u00e1nchez-Prieto J et al (2023) Control of a hippocampal recurrent excitatory circuit by cannabinoid receptor-interacting protein Gap43. Nat Commun 14:2303","journal-title":"Nat Commun"},{"key":"54_CR38","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/nature00839","volume":"418","author":"G Marsicano","year":"2002","unstructured":"Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascioll MG, Hermann H, Tang J, Hofmann C, Zieglg\u00e4nsberger W et al (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature 418:530\u2013534","journal-title":"Nature"},{"key":"54_CR39","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/s41589-018-0129-x","volume":"14","author":"ME Matyskiela","year":"2018","unstructured":"Matyskiela ME, Couto S, Zheng X, Lu G, Hui J, Stamp K, Drew C, Ren Y, Wang M, Carpenter A et al (2018) SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate. Nat Chem Biol 14:981\u2013987","journal-title":"Nat Chem Biol"},{"key":"54_CR40","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nrn3811","volume":"15","author":"R Mechoulam","year":"2014","unstructured":"Mechoulam R, Hanu\u0161 LO, Pertwee R, Howlett AC (2014) Early phytocannabinoid chemistry to endocannabinoids and beyond. Nat Rev Neurosci 15:757\u2013764","journal-title":"Nat Rev Neurosci"},{"key":"54_CR41","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/mp.2012.145","volume":"18","author":"FJ Meye","year":"2013","unstructured":"Meye FJ, Trezza V, Vanderschuren LJMJ, Ramakers GMJ, Adan RAH (2013) Neutral antagonism at the cannabinoid 1 receptor: a safer treatment for obesity. Mol Psychiatry 18:1294\u20131301","journal-title":"Mol Psychiatry"},{"key":"54_CR42","doi-asserted-by":"publisher","first-page":"e269","DOI":"10.1371\/journal.pbio.0050269","volume":"5","author":"K Monory","year":"2007","unstructured":"Monory K, Blaudzun H, Massa F, Kaiser N, Lemberger T, Sch\u00fctz G, Wotjak CT, Lutz B, Marsicano G (2007) Genetic dissection of behavioural and autonomic effects of \u03949-tetrahydrocannabinol in mice. PLoS Biol 5:e269","journal-title":"PLoS Biol"},{"key":"54_CR43","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.neuron.2006.07.006","volume":"51","author":"K Monory","year":"2006","unstructured":"Monory K, Massa F, Egertov\u00e1 M, Eder M, Blaudzun H, Westenbroek R, Kelsch W, Jacob W, Marsch R, Ekker M et al (2006) The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 51:455\u2013466","journal-title":"Neuron"},{"key":"54_CR44","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/npp.2015.166","volume":"41","author":"M Morena","year":"2016","unstructured":"Morena M, Patel S, Bains JS, Hill MN (2016) Neurobiological interactions between stress and the endocannabinoid system. Neuropsychopharmacology 41:80\u2013102","journal-title":"Neuropsychopharmacology"},{"key":"54_CR45","doi-asserted-by":"publisher","first-page":"7063","DOI":"10.1021\/bi992760w","volume":"39","author":"FJ Moy","year":"2000","unstructured":"Moy FJ, Chanda PK, Cockett MI, Edris W, Jones PG, Mason K, Semus S, Powers R (2000) NMR structure of free RGS4 reveals an induced conformational change upon binding G\u03b1. Biochemistry 39:7063\u20137073","journal-title":"Biochemistry"},{"key":"54_CR46","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.nbd.2019.01.014","volume":"125","author":"A Navarro-Romero","year":"2019","unstructured":"Navarro-Romero A, V\u00e1zquez-Oliver A, Gomis-Gonz\u00e1lez M, Garz\u00f3n-Montesinos C, Falc\u00f3n-Moya R, Pastor A, Mart\u00edn-Garc\u00eda E, Pizarro N, Busquets-Garcia A, Revest JM et al (2019) Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome. Neurobiol Dis 125:92\u2013106","journal-title":"Neurobiol Dis"},{"key":"54_CR47","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1124\/mol.107.039263","volume":"72","author":"JL Niehaus","year":"2007","unstructured":"Niehaus JL, Liu Y, Wallis KT, Egertov\u00e1 M, Bhartur SG, Mukhopadhyay S, Shi S, He H, Selley DE, Howlett AC et al (2007) CB1 cannabinoid receptor activity is modulated by the cannabinoid receptor interacting protein CRIP 1a. Mol Pharmacol 72:1557\u20131566","journal-title":"Mol Pharmacol"},{"key":"54_CR48","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41589-018-0055-y","volume":"14","author":"RP Nowak","year":"2018","unstructured":"Nowak RP, Deangelo SL, Buckley D, He Z, Donovan KA, An J, Safaee N, Jedrychowski MP, Ponthier CM, Ishoey M et al (2018) Plasticity in binding confers selectivity in ligand-induced protein degradation article. Nat Chem Biol 14:706\u2013714","journal-title":"Nat Chem Biol"},{"key":"54_CR49","doi-asserted-by":"publisher","first-page":"6942","DOI":"10.1021\/acs.jmedchem.7b00443","volume":"60","author":"T Okawa","year":"2017","unstructured":"Okawa T, Aramaki Y, Yamamoto M, Kobayashi T, Fukumoto S, Toyoda Y, Henta T, Hata A, Ikeda S, Kaneko M et al (2017) Design, synthesis, and evaluation of the highly selective and potent G-protein-coupled receptor kinase 2 (GRK2) inhibitor for the potential treatment of heart failure. J Med Chem 60:6942\u20136990","journal-title":"J Med Chem"},{"key":"54_CR50","doi-asserted-by":"publisher","first-page":"e3651","DOI":"10.21769\/BioProtoc.3651","volume":"10","author":"JF Oliveira da Cruz","year":"2020","unstructured":"Oliveira da Cruz JF, Gomis-Gonzalez M, Maldonado R, Marsicano G, Ozaita A, Busquets-Garcia A (2020) An alternative maze to assess novel object recognition in mice. Bio Protoc 10:e3651","journal-title":"Bio Protoc"},{"key":"54_CR51","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/febs.12260","volume":"280","author":"P Pacher","year":"2013","unstructured":"Pacher P, Kunos G (2013) Modulating the endocannabinoid system in human health and disease\u2014successes and failures. FEBS J 280:1918\u20131943","journal-title":"FEBS J"},{"key":"54_CR52","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ejmg.2015.03.005","volume":"58","author":"SM Papuc","year":"2015","unstructured":"Papuc SM, Hackmann K, Andrieux J, Vincent-Delorme C, Budi\u015fteanu M, Arghir A, Schrock E, \u0162u\u0163ulan-Cuni\u0163a AC, Di Donato N (2015) Microduplications of 3p26.3p26.2 containing CRBN gene in patients with intellectual disability and behavior abnormalities. Eur J Med Genet 58:319\u2013323","journal-title":"Eur J Med Genet"},{"key":"54_CR53","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1093\/eurheartj\/ehac072","volume":"43","author":"N Park","year":"2022","unstructured":"Park N, Marquez J, Pham TK, Ko TH, Youm JB, Kim M, Choi SH, Moon J, Flores J, Ko KS et al (2022) Cereblon contributes to cardiac dysfunction by degrading Cav1.2\u03b1. Eur Heart J 43:1973\u20131989","journal-title":"Eur Heart J"},{"key":"54_CR54","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1124\/pr.110.003004","volume":"62","author":"RG Pertwee","year":"2010","unstructured":"Pertwee RG, Howlett AC, Abood ME, Alexander SPH, Di Marzo V, Elphick MR, Greasley PJ, Hansen HS, Kunos G, Mackie K et al (2010) International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev 62:588\u2013631","journal-title":"Pharmacol Rev"},{"key":"54_CR55","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nature09146","volume":"466","author":"D Pinto","year":"2010","unstructured":"Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, Conroy J, Magalhaes TR, Correia C, Abrahams BS et al (2010) Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466:368\u2013372","journal-title":"Nature"},{"key":"54_CR56","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nrn1247","volume":"4","author":"D Piomelli","year":"2003","unstructured":"Piomelli D (2003) The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4:873\u2013884","journal-title":"Nat Rev Neurosci"},{"key":"54_CR57","doi-asserted-by":"publisher","first-page":"R764","DOI":"10.1016\/j.cub.2013.05.041","volume":"23","author":"AR Preston","year":"2013","unstructured":"Preston AR, Eichenbaum H (2013) Interplay of hippocampus and prefrontal cortex in memory. Curr Biol 23:R764\u2013R773","journal-title":"Curr Biol"},{"key":"54_CR58","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.bbr.2011.09.039","volume":"226","author":"AM Rajadhyaksha","year":"2012","unstructured":"Rajadhyaksha AM, Ra S, Kishinevsky S, Lee AS, Romanienko P, DuBoff M, Yang C, Zupan B, Byrne M, Daruwalla ZR et al (2012) Behavioral characterization of cereblon forebrain-specific conditional null mice: a model for human non-syndromic intellectual disability. Behav Brain Res 226:428\u2013434","journal-title":"Behav Brain Res"},{"key":"54_CR59","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan\u2010Shaw","year":"2008","unstructured":"Reagan\u2010Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22:659\u2013661","journal-title":"FASEB J"},{"key":"54_CR60","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/sj.bjp.0706687","volume":"147","author":"MR Romano","year":"2006","unstructured":"Romano MR, Lograno MD (2006) Cannabinoid agonists induce relaxation in the bovine ophthalmic artery: evidences for CB1 receptors, nitric oxide and potassium channels. Br J Pharmacol 147:917\u2013925","journal-title":"Br J Pharmacol"},{"key":"54_CR61","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/cercor\/bhx285","volume":"28","author":"A Ruiz-Calvo","year":"2018","unstructured":"Ruiz-Calvo A, Maroto IB, Bajo-Gra\u00f1eras R, Chiarlone A, Gaudioso \u00c1, Ferrero JJ, Resel E, S\u00e1nchez-Prieto J, Rodr\u00edguez-Navarro JA, Marsicano G et al (2018) Pathway-specific control of striatal neuron vulnerability by corticostriatal cannabinoid CB1 receptors. Cereb Cortex 28:307\u2013322","journal-title":"Cereb Cortex"},{"key":"54_CR62","unstructured":"Schalock RL, Borthwick-Duffy SA, Bradley VJ, Buntinx WHE, Coulter DL, Craig EM, Gomez SC, Lachapelle Y, Luckasson R, Reeve A et al (2010) Intellectual disability: definition, classification, and systems of supports. Eleventh edition, vol. 33. American Association on Intellectual and Developmental Disabilities, p 386"},{"key":"54_CR63","doi-asserted-by":"publisher","first-page":"5080","DOI":"10.1093\/nar\/23.24.5080","volume":"23","author":"F Schwenk","year":"1995","unstructured":"Schwenk F, Baron U, Rajewsky K (1995) A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res 23:5080\u20135081","journal-title":"Nucleic Acids Res"},{"key":"54_CR64","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1136\/jmedgenet-2016-104117","volume":"54","author":"A Sheereen","year":"2017","unstructured":"Sheereen A, Alaamery M, Bawazeer S, Al Yafee Y, Massadeh S, Eyaid W (2017) A missense mutation in the CRBN gene that segregates with intellectual disability and self-mutilating behaviour in a consanguineous Saudi family. J Med Genet 54:236\u2013240","journal-title":"J Med Genet"},{"key":"54_CR65","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.exer.2004.12.003","volume":"80","author":"F Stumpff","year":"2005","unstructured":"Stumpff F, Boxberger M, Krauss A, Rosenthal R, Meissner S, Choritz L, Wiederholt M, Thieme H (2005) Stimulation of cannabinoid (CB1) and prostanoid (EP2) receptors opens BKCa channels and relaxes ocular trabecular meshwork. Exp Eye Res 80:697\u2013708","journal-title":"Exp Eye Res"},{"key":"54_CR66","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bbr.2008.12.035","volume":"200","author":"G Thiemann","year":"2009","unstructured":"Thiemann G, Watt CA, Ledent C, Molleman A, Hasen\u00f6hrl RU (2009) Modulation of anxiety by acute blockade and genetic deletion of the CB1 cannabinoid receptor in mice together with biogenic amine changes in the forebrain. Behav Brain Res 200:60\u201367","journal-title":"Behav Brain Res"},{"key":"54_CR67","doi-asserted-by":"publisher","first-page":"e1002194","DOI":"10.1371\/journal.pbio.1002194","volume":"13","author":"X Vi\u00f1als","year":"2015","unstructured":"Vi\u00f1als X, Moreno E, Lanfumey L, Cordom\u00ed A, Pastor A, de La Torre R, Gasperini P, Navarro G, Howell LA, Pardo L et al. (2015) Cognitive impairment induced by delta-9-tetrahydrocannabinol occurs through heteromers between cannabinoid CB1 and serotonin 5-HT2A Receptors. PLoS Biol 13:e1002194","journal-title":"PLoS Biol"},{"key":"54_CR68","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/sj.bjp.0706157","volume":"145","author":"JL Wiley","year":"2005","unstructured":"Wiley JL, Burston JJ, Leggett DC, Alekseeva OO, Razdan RK, Mahadevan A, Martin BR (2005) CB1 cannabinoid receptor-mediated modulation of food intake in mice. Br J Pharmacol 145:293\u2013300","journal-title":"Br J Pharmacol"},{"key":"54_CR69","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1126\/science.1063545","volume":"296","author":"RI Wilson","year":"2002","unstructured":"Wilson RI, Nicoll RA (2002) Neuroscience: endocannabinoid signaling in the brain. Science 296:678\u2013682","journal-title":"Science"},{"key":"54_CR70","doi-asserted-by":"publisher","first-page":"29573","DOI":"10.1074\/jbc.M113.472092","volume":"288","author":"G Xu","year":"2013","unstructured":"Xu G, Jiang X, Jaffrey SR (2013) A mental retardation-linked nonsense mutation in cereblon is rescued by proteasome inhibition. J Biol Chem 288:29573\u201329585","journal-title":"J Biol Chem"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-024-00054-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-024-00054-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-024-00054-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T18:04:20Z","timestamp":1785780260000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-024-00054-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":70,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4,15]]}},"alternative-id":["54"],"URL":"https:\/\/doi.org\/10.1038\/s44321-024-00054-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.07.24.550332","asserted-by":"object"}]},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,21]]},"assertion":[{"value":"24 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}],"article-number":"11"}}